1,200
Participants
Start Date
Not specified
Primary Completion Date
May 31, 1996
Valacyclovir hydrochloride
Acyclovir
Mount Sinai Med Ctr, New York
North Central Bronx Hosp / Bronx Municipal Hosp, The Bronx
Birmingham Veterans Administration Med Ctr, Birmingham
Northwestern Univ Med School, Chicago
Washington Univ, St Louis
Univ of Colorado Health Sciences Ctr, Denver
Los Angeles County - USC Med Ctr, Los Angeles
Kaiser Permanente Med Ctr, San Francisco
Univ of Washington / Madison Clinic, Seattle
Girard Med Ctr, Philadelphia
Johns Hopkins Hosp, Baltimore
Univ of North Carolina School of Medicine, Chapel Hill
Ohio State Univ Hosp Clinic, Columbus
Indiana Univ Hosp, Indianapolis
Univ TX Galveston Med Branch, Galveston
CARE Ctr / UCLA Med Ctr, Los Angeles
Univ of California / San Diego Treatment Ctr, San Diego
Highland Gen Hosp / San Francisco Gen Hosp, Oakland
Yale Univ, New Haven
Harvard (Massachusetts Gen Hosp), Boston
Boston Med Ctr, Boston
Saint Vincent's Hosp Med Centre, Sydney
Southern Alberta HIV Clinic / Foothills Hosp, Calgary
Sunnybrook Health Science Ctr, Toronto
Toronto Hosp, Toronto
Montreal Chest Institute, Montreal
Montreal Gen Hosp, Montreal
Hvidovre Univ Hosp, Hvidore
Services des Maladies Infectieuses, Paris
Universitatsklinikum Rudolf Virchow, Berlin
Universita Cattolica del Sacro Cuore, Rome
South Hosp, Stockholm
Medizinische Universibatspoliklinik Infekbiologie, Bern
Royal Free Hosp, London
Westminster Hosp, London
Collaborators (1)
Glaxo Wellcome
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH